| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/09/2009 | WO2009084743A1 External preparation for preventive or therapeutic use |
| 07/09/2009 | WO2009084653A1 Method for screening of cell-protecting agent |
| 07/09/2009 | WO2009084588A1 Water-containing composition which can be used as external composition |
| 07/09/2009 | WO2009084477A1 Preparation for external application to skin and cosmetic preparation |
| 07/09/2009 | WO2009084471A1 Emulsion preparation for external application to skin and cosmetic preparation |
| 07/09/2009 | WO2009084200A1 External skin preparation for pimpled skin |
| 07/09/2009 | WO2009083768A2 Use of partly hydrolyzed fish gelatin for the preparation of topically administered pharmaceutical compositions |
| 07/09/2009 | WO2009083203A2 Topical application and formulation of erythropoietin for skin wound healing |
| 07/09/2009 | US20090176881 Unsaturated Alkyl Esters of 5-Aminolevulinic Acid, their Preparation and their Use |
| 07/09/2009 | US20090176876 Compositions, kits and regimens for the treatment of skin, especially decolletage |
| 07/09/2009 | US20090176872 Carotenoid Composition and Method for Protecting Skin |
| 07/09/2009 | US20090176853 Adamantane derivatives |
| 07/09/2009 | US20090176810 Composition for skin external application containing gallocatechin gallate for moisturizing effect on the skin |
| 07/09/2009 | US20090176807 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 07/09/2009 | US20090176806 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-(2-chlorophenyl)-4-[1-(3-hydroxypropyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2,5-dione, used for treating cardiovascular, skin, nervous system disorders and immunological disorders, diabetes, inflammatory diseases and cancer |
| 07/09/2009 | US20090176804 2-phenyl-indoles as prostaglandin d2 receptor antagonists |
| 07/09/2009 | US20090176750 Specified ratio of penetration enhancers to solvents and emulsifiers; fluocinolone |
| 07/09/2009 | US20090176749 Oil-in-water emulsion lotion containing 22-oxa-1alpha, 25-dihydroxyvitamin d3 and method of treatment of skin disorder using the same |
| 07/09/2009 | US20090176741 Modulation of the immune system by inositol phospholipids |
| 07/09/2009 | US20090176738 Dermal medicament delivery system |
| 07/09/2009 | US20090176719 Compositions and methods for treating perioral dermatitis |
| 07/09/2009 | US20090175965 Antiscarring, antiaging, photodamaged skin or as a depilatory; unsaponifiable component from canola oil, rapeseed oil, sunflower oil, palm oil, maize oil, sesame oil, wheatgerm oil and one from avocado oil, lupin oil, or soybean oil |
| 07/09/2009 | US20090175946 Use of gelatin and a cross-linking agent for producing cross-linking medical glues |
| 07/09/2009 | US20090175926 Topical burn treatment |
| 07/09/2009 | US20090175893 Albumin-Fused Anti-Angiogenesis Peptides |
| 07/09/2009 | US20090175811 Use of compound that inactivates protein kinase a in a composition containing a cosmetically acceptable medium for lightening the skin |
| 07/09/2009 | US20090175806 Antimicrobial Compositions Containing Low Concentrations of Botanicals |
| 07/09/2009 | CA2710977A1 2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin d analogs |
| 07/09/2009 | CA2710974A1 2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs |
| 07/09/2009 | CA2710970A1 2-methylene-(20s,25r)-19,26-dinor-vitamin d analogs |
| 07/09/2009 | CA2710966A1 (20r)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs |
| 07/09/2009 | CA2710954A1 (20s)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs |
| 07/09/2009 | CA2710388A1 Treatment of abnormal or excessive scars |
| 07/09/2009 | CA2710387A1 Treatment of fibrotic conditions |
| 07/09/2009 | CA2710380A1 Treatment of fibrotic conditions |
| 07/09/2009 | CA2710232A1 Treatment of abnormal or excessive scars |
| 07/09/2009 | CA2709545A1 Topical application and formulation of erythropoietin for skin wound healing |
| 07/09/2009 | CA2707789A1 Phenyl acetic acid derivatives as inflammation modulators |
| 07/08/2009 | EP2077277A1 Use of mammalian cytokine; related reagents |
| 07/08/2009 | EP2077118A1 Clottable concentrate of platelet growth factors and preparation method thereof |
| 07/08/2009 | EP2077110A1 Glutamine-containing composition for increasing blood flow |
| 07/08/2009 | EP2076290A1 Multimeric tie 2 agonists and uses thereof in stimulating angiogenesis |
| 07/08/2009 | EP2076279A2 Native (telopeptide) placental collagen compositions |
| 07/08/2009 | EP2076266A2 Method of treating inflammatory diseases using tyroskine kinase inhibitors |
| 07/08/2009 | EP1620116B1 Use of quinquina for the preparation of a medicament stimulating angiogenesis |
| 07/08/2009 | EP1539933A4 Methods of organ regeneration |
| 07/08/2009 | EP1511740B1 Phenyl-thiophene type vitamin d receptor modulators |
| 07/08/2009 | EP1495022B1 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
| 07/08/2009 | EP1455806B1 Active agent mixture containing a plant extract of convolvulaceae for treating hair problems, skin disorders and skin diseases |
| 07/08/2009 | EP1383927B1 New polynucleotides and polypeptides of the erythropoietin gene |
| 07/08/2009 | EP1232175B1 Method of forming a peptide-receptor complex with zsig33 polypeptides. |
| 07/08/2009 | EP0738142B1 Perfluorocarbons as anti-inflammatory agents |
| 07/08/2009 | CN100510073C Tryptase inhibitor |
| 07/08/2009 | CN100509846C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/08/2009 | CN100509811C Azaindoles |
| 07/08/2009 | CN100509810C Substituted beta-carbolines |
| 07/08/2009 | CN100509805C 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 07/08/2009 | CN100509782C NK* antagonists |
| 07/08/2009 | CN100509774C Acylsulfonamides as inhibitors of steroid sulfatase |
| 07/08/2009 | CN100509773C Alpha -amino-n-hydroxy-acetamide derivatives |
| 07/08/2009 | CN100509055C Use of thrombin-derived peptides for the therapy of chronic dermal ulcers |
| 07/08/2009 | CN100508990C Acrochordon alleviation |
| 07/08/2009 | CN100508988C Carbon dioxide external preparation and material for formation of carbon dioxide external preparation |
| 07/08/2009 | CN100508978C Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 07/08/2009 | CN100508943C Substance capable of potentiating laminin 5 productivity in epidermal cells and utilization thereof |
| 07/07/2009 | US7557210 Antiinflamamtory agents |
| 07/07/2009 | US7557141 Method of treating autoimmune diseases |
| 07/07/2009 | US7557140 e.g. 3-[3-(2,4-Difluoro-phenylsulfamoyl)-phenyl]-N-hydroxy-acrylamide; histone deacetylase inhibitor; anticarcinogenic, antiinflammatory agent, autoimmune diseases; leukemia, atheriosclerosis, Alzheimer's disease, rheumatoid arthritis, psoriasis |
| 07/07/2009 | US7557128 Having antiallergic and anti-inflammatory effects while being devoid of the severe dose-limiting sedative side effects of ketotifen |
| 07/07/2009 | US7557110 Pyrazolo[1,5-A] pyrimidine derivatives |
| 07/07/2009 | US7557094 Complex of chitosan, conjugated linoleic acid, vitamin a and cyclodextrin |
| 07/07/2009 | CA2486101C Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 07/07/2009 | CA2388809C A topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties |
| 07/07/2009 | CA2378834C Pyrazinones, compositions containing such compounds |
| 07/02/2009 | WO2009082511A1 Methods and compositions for treating skin |
| 07/02/2009 | WO2009082185A1 Skin-whitening agent containing platycodin d |
| 07/02/2009 | WO2009081789A1 Sulfonyl substituted 6-membered ring derivative |
| 07/02/2009 | WO2009081587A1 External preparation for skin |
| 07/02/2009 | WO2009081581A1 Composition for treatment or prevention of atopic dermatitis |
| 07/02/2009 | WO2009080857A1 Method for obtaining melanins and use thereof |
| 07/02/2009 | WO2009080850A1 Method for increasing the therapeutic efficacy of curcuminoids and analogues |
| 07/02/2009 | WO2009080842A1 Photoprotective compositions |
| 07/02/2009 | WO2009080728A1 Oxadiazole derivatives active on sphingosine-1-phosphate (sip) |
| 07/02/2009 | WO2009080725A1 Oxadiazole derivatives active on sphingosine-1-phosphate (sip) |
| 07/02/2009 | WO2009080724A1 Oxadiazole derivatives active on sphingosine-1-phosphate (s1p) |
| 07/02/2009 | WO2009079877A1 The dermatological compound preparation for oxidative stress interference period |
| 07/02/2009 | WO2009079822A1 A bcg polysaccharide nucleic acid extractive and preparation method thereof |
| 07/02/2009 | WO2009079692A1 Halogenated analogues of anti-fibrotic agents |
| 07/02/2009 | WO2009079680A1 Use larch wood material for treating inflammation |
| 07/02/2009 | WO2009061445A3 Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction |
| 07/02/2009 | WO2009012375A3 Squarate kinase inhibitors |
| 07/02/2009 | WO2009009417A3 Pharmaceutical compositions and methods of preventing, treating, or inhibiting inflammatory diseases, disorders, or conditions of the skin, and diseases, disorders, or conditions associated with collagen depletion |
| 07/02/2009 | WO2008142198A3 A method for inhibiting or stimulating angiogenesis in an individual |
| 07/02/2009 | WO2008125520A3 Cleome spinosa extract used in pharmaceutical preparations and cosmetic compositions |
| 07/02/2009 | US20090171086 2,4-pyrimidinediamine compounds and their uses |
| 07/02/2009 | US20090171085 N2,N4-bis(4-ethoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 07/02/2009 | US20090170943 moisturizing skin by contact with the product of reacting poly-hydroxy functional compound such as 1,2,3,4,5,6-hexanehexol with ethylene oxide and/or 1,2-propylene oxide and reacting the product with a C8-22 fatty acid; each oxyalkylene chain contains no more than 5 units |
| 07/02/2009 | US20090170892 3-Hydroxy-6-phenylphenanthridines as pde4 inhibitors |
| 07/02/2009 | US20090170881 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170879 6,9-Disubstituted Purine Derivatives and Their Use as Cosmetics and Cosmetic Compositions |